91st General Assembly
Status of HB0154
   [ Home ]   [ Back ]   [ Legislation ]
Legislation:  
Please enter a bill number.



 Full Text  Bill Summary
JOHNSON,TIM-ERWIN-CURRY,JULIE-ZICKUS-HOFFMAN, GRANBERG, 
   FEIGENHOLTZ, GASH, RONEN, CROTTY, REITZ, O'BRIEN, 
   DAVIS,MONIQUE, MCGUIRE, WOOLARD, DAVIS,STEVE, NOVAK, 
   SLONE, BROSNAHAN, MCCARTHY AND GARRETT.

(LAUZEN-SHAW)

   5 ILCS 375/6.11                                                             
   20 ILCS 2310/55.70                                                          
   20 ILCS 2310/55.91 new                                                      
   30 ILCS 105/5.362                                                           
   30 ILCS 805/8.23 new                                                        
   35 ILCS 5/507L                                                              
   35 ILCS 5/509             from Ch. 120, par. 5-509                          
   35 ILCS 5/510             from Ch. 120, par. 5-510                          
   55 ILCS 5/5-1069.3                                                          
   65 ILCS 5/10-4-2.3                                                          
   105 ILCS 5/10-22.3f                                                         
   215 ILCS 5/356y new                                                         
   215 ILCS 5/356z new                                                         
   215 ILCS 125/5-3          from Ch. 111 1/2, par. 1411.2                     
   215 ILCS 165/10           from Ch. 32, par. 604                             

        Amends the State Employees  Group  Insurance  Act  of  1971,  the      
   Counties  Code,  the  Illinois  Municipal  Code,  the School Code, the      
   Illinois Insurance Code, the Health Maintenance Organization Act,  and      
   the  Voluntary  Health  Services Plans Act to require coverage for all      
   drugs approved by the Food and Drug Administration that are  used  for      
   the  treatment  or  prevention  of  breast  cancer, for computer-aided      
   diagnosis of breast cancer, and for nutritional and dietary  therapies      
   for  breast  cancer. Provides that health benefit coverage under those      
   Acts must include coverage  for  patient  care  provided  pursuant  to      
   investigational  cancer  treatments.  Amends the State Mandates Act to      
   provide that no reimbursement is required for any mandate  created  by      
   this amendatory Act. Amends the Civil Administrative Code and the           
   State Finance Act. Changes the name of the Breast and Cervical Cancer       
   Research Fund to the Breast, Cervical, and Prostate Cancer Research         
   Fund and authorizes expenditures for prostate cancer research. Esta-        
   blishes the Breast Cancer Treatment Advisory Committee to advise the        
   General Assembly regarding legislation necessary or desirable for the       
   improvement of the treatment of breast cancer. Amends the Illinois          
   Income Tax Act to continue the checkoff for the Breast, Cervical, and       
   Prostate Cancer Research Fund until Ocotber 1, 2004 without regard to       
   the amount of money received by the Fund. Effective immediately.            
        HOUSE AMENDMENT NO. 1.                                                 
          Deletes reference to:                                                
          20 ILCS 2310/55.70                                                   
          30 ILCS 105/5.362                                                    
          35 ILCS 5/507L                                                       
          35 ILCS 5/510                                                        
          215 ILCS 5/356z new                                                  
        Removes provisions changing the name of the Breast  and  Cervical      
   Cancer Research Fund and providing checkoff funds for prostate cancer.      
   Replaces  provisions  specifying  coverage  for  certain breast cancer      
   treatments  and  investigational  cancer  treatments  with  provisions      
   requiring  coverage  of  certain  investigational  cancer  treatments.      
   Provides that qualifying investigational  cancer  treatments  must  be      
   part of an approved research trial in Phase II, Phase III, or Phase IV      
   of  investigation.  Requires  at  least 4 members of the Breast Cancer      
   Treatment Advisory Committee to  be  physicians.   Provides  that  the      
   coverage for drugs and other items or services is for drugs, services,      
   and  items  prescribed  by  or  ordered  by  a  physician. Repeals the      
   coverage requirements on January 1, 2003.                                   
        SENATE AMENDMENT NO. 1.                                                
          Deletes reference to:                                                
          5 ILCS 375/6.11                                                      
          30 ILCS 805/8.23 new                                                 
          55 ILCS 5/5-1069.3                                                   
          65 ILCS 5/10-4-2.3                                                   
          105 ILCS 5/10-22.3f                                                  
          215 ILCS 5/356y new                                                  
          215 ILCS 125/5-3                                                     
          215 ILCS 165/10                                                      
        Replaces the title and everything after the enacting clause.           
   Amends the Civil Administrative Code of Illinois to create the Breast       
   Cancer Treatment Advisory Committee. Directs the committee to review        
   techniques and modalities for the treatment and prevention of breast        
   cancer and make recommendations to the General Assembly regarding           
   legislation to improve the treatment of breast cancer. Amends the           
   Illinois Income Tax Act to provide that the checkoff for the Breast         
   and Cervical Cancer Research Fund shall continue until at least Octo-       
   ber 1, 2004.                                                                
   99-01-13  H  FILED WITH CLERK                                               
   99-01-13  H  ADDED AS A JOINT SPONSOR                 ERWIN                 
   99-01-13  H  ADDED AS A CO-SPONSOR                    CURRY,JULIE           
   99-01-13  H  ADDED AS A CO-SPONSOR                    ZICKUS                
   99-01-14  H  FIRST READING                                                  
   99-01-14  H  REFERRED TO HOUSE RULES COMMITTEE        RULES                 
   99-01-25  H  ADDED AS A CO-SPONSOR                    GRANBERG              
   99-01-27  H       ASSIGNED TO COMMITTEE               INSURANCE             
   99-02-01  H  ADDED AS A CO-SPONSOR                    HOLBROOK              
   99-02-03  H  ADDED AS A CO-SPONSOR                    HOFFMAN               
   99-02-03  H  ADDED AS A CO-SPONSOR                    FEIGENHOLTZ           
   99-02-03  H  ADDED AS A CO-SPONSOR                    GASH                  
   99-02-03  H  ADDED AS A CO-SPONSOR                    RONEN                 
   99-02-09  H  ADDED AS A CO-SPONSOR                    CROTTY                
   99-02-10  H  ADDED AS A CO-SPONSOR                    REITZ                 
   99-02-11  H  ADDED AS A CO-SPONSOR                    O'BRIEN               
   99-02-11  H  ADDED AS A CO-SPONSOR                    HAMOS                 
   99-02-11  H  ADDED AS A CO-SPONSOR                    DAVIS,MONIQUE         
   99-02-11  H  ADDED AS A CO-SPONSOR                    MCGUIRE               
   99-02-24  H  ADDED AS A CO-SPONSOR                    WOOLARD               
   99-02-24  H  ADDED AS A CO-SPONSOR                    DAVIS,STEVE           
   99-02-24  H  ADDED AS A CO-SPONSOR                    NOVAK                 
   99-02-25  H                             AMENDMENT NO. 01-INSURANCE     H    
   99-02-25  H                                   ADOPTED                       
   99-02-25  H  DO PASS AMENDED/SHORT DEBATE             011-004-000   HINS    
   99-02-25  H  PLACED CALENDAR 2ND READING-SHORT DEBATE                       
   99-03-02  H  ADDED AS A CO-SPONSOR                    HANNIG                
   99-03-03  H                             AMENDMENT NO. 02-JOHNSON,TIM        
   99-03-03  H                     AMENDMENT REFERRED TO HRUL                  
   99-03-03  H  CALENDAR ORDER 2ND READING-SHORT DEBATE                        
   99-03-03  H  ADDED AS A CO-SPONSOR                    SLONE                 
   99-03-10  H  ADDED AS A CO-SPONSOR                    BROSNAHAN             
   99-03-10  H  SECOND READING-SHORT DEBATE                                    
   99-03-10  H  PLCD CAL ORDER 3RD READING-SHORT DEBATE                        
   99-03-11  H  TABLED PURSUANT TO RULE 40(a)            HOUSE AMEND 2         
   99-03-11  H  THIRD READING/SHORT DEBATE/PASSED        111-004-000           
   99-03-11  S  ARRIVE IN SENATE                                               
   99-03-11  S  PLACED CALENDAR ORDER OF FIRST READING   99-03-16              
   99-03-11  H  ADDED AS A CO-SPONSOR                    MCCARTHY              
   99-03-11  H  ADDED AS A CO-SPONSOR                    GARRETT               
   99-03-25  S  CHIEF SPONSOR                            LAUZEN                
   99-03-25  S  FIRST READING                                                  
   99-03-25  S  REFERRED TO SENATE RULES COMMITTEE       RULES                 
   99-04-20  S       ASSIGNED TO COMMITTEE               INS & PENS.           
   99-05-04  S                             AMENDMENT NO. 01-INS & PENS.   S    
   99-05-04  S                                   ADOPTED                       
   99-05-04  S       DO PASS AS AMENDED                  008-000-000   SINS    
   99-05-04  S  PLACED ON CALENDAR ORDER OF 2ND READING  99-05-05              
   99-05-07  S  ADDED AS A CHIEF CO-SPONSOR              SHAW                  
   99-05-11  S  FILED WITH SECRETARY                                           
   99-05-11  S                             AMENDMENT NO. 02-LAUZEN             
   99-05-11  S                     AMENDMENT REFERRED TO SRUL                  
   99-05-11  S  CALENDAR ORDER OF 2ND READING            99-05-05              
   99-06-27  S  REFER TO RULES/PURSUANT SEN RULE 3-9 (B) RULES         SRUL    
   99-06-27  S  TABLED PURSUANT TO RULE                  5-4(A) SA 02          
   99-06-27  S                   COMMITTEE               RULES                 
   01-01-09  H  SESSION SINE DIE                                               

   END OF INQUIRY 



 Full Text  Bill Summary